Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 4/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120722 | 1.00 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL3719973 | 0.98 | LPAR3 (0.54) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL3712984 | 0.98 | LPAR3 (0.54) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL672379 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL7127580 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL674424 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| Phosphonic Acid SCHEMBL28417856 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL3962398 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| SCHEMBL639814 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 | |
| Butane SCHEMBL3793662 | 0.96 | LPAR3 (0.53) | LPAR3LPAR1LPAR2FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080063714-A1 | Compositions for Encapsulation and Controlled Release | 3M INNOVATIVE PROPERTIES COMPANY | 2008-03-13 | — | — | US | disclosed |
| EP-1651035-A2 | COMPOSITIONS FOR ENCAPSULATION AND CONTROLLED RELEASE | 3M Innovative Properties Company (US) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005012488-A2 | COMPOSITIONS FOR ENCAPSULATION AND CONTROLLED RELEASE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080063714-A1 | Compositions for Encapsulation and Controlled Release | CHMP4B, DDC, ANXA5 | LPAR3 3862/4885LPAR1 4213/4885LPAR2 4380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.